B. Riley Securities resumed coverage on Eton Pharmaceuticals with a new price target
$ETON
Biotechnology: Pharmaceutical Preparations
Health Care
B. Riley Securities resumed coverage of Eton Pharmaceuticals with a rating of Buy and set a new price target of $10.00